Bill

Bill > H2495


MA H2495

MA H2495
Relative to LSDs (Lysosomal Storage Disorders) in infants


summary

Introduced
02/27/2025
In Committee
02/27/2025
Crossed Over
Passed
Dead

Introduced Session

194th General Court

Bill Summary

For legislation relative to LSDs (Lysosomal Storage Disorders) in infants. Public Health.

AI Summary

This bill amends Section 110A of Chapter 111 of the Massachusetts General Laws to expand the list of recognized Lysosomal Storage Disorders (LSDs) in infants. LSDs are a group of rare genetic disorders caused by enzyme deficiencies that lead to the abnormal buildup of substances in cells, which can cause serious health problems. Specifically, the bill adds six additional LSD conditions to the existing law: Krabbe disease, Fabry disease, Gaucher disease, Pompe disease, MPS I (Mucopolysaccharidosis Type I), and Niemann-Pick Types A and B. By including these specific disorders in the law, the bill likely aims to improve awareness, screening, diagnosis, and potentially treatment protocols for these rare genetic conditions in newborns and infants. The amendment appears to be a technical update to expand medical recognition and potentially support for these specific lysosomal storage disorders within the state's public health framework.

Committee Categories

Health and Social Services

Sponsors (1)

Last Action

Accompanied a study order, see H5235 (on 03/16/2026)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Document Type Source Location
State Bill Page https://malegislature.gov/Bills/194/H2495
BillText https://malegislature.gov/Bills/194/H2495.pdf
Loading...